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a b s t r a c t
Human dihydrolipoamide dehydrogenase (hLADH) is a flavoenzyme component (E3) of the human alpha-
ketoglutarate dehydrogenase complex (α-KGDHc) and few other dehydrogenase complexes. Pathogenic
mutations of hLADH cause severe metabolic diseases (atypical forms of E3 deficiency) that often escalate to
cardiological or neurological presentations and even premature death; the pathologies are generally
accompanied by lactic acidosis. hLADH presents a distinct conformation under acidosis (pH 5.5–6.8) with
lower physiological activity and the capacity of generating reactive oxygen species (ROS). It has been
shown by our laboratory that selected pathogenic mutations, besides lowering the physiological activity of
hLADH, significantly stimulate ROS generation by hLADH, especially at lower pH, which might play a role
in the pathogenesis of E3-deficiency in respective cases. Previously, we generated by molecular dynamics
(MD) simulation the low-pH hLADH structure and analyzed the structural changes induced in this
structure by eight of the pathogenic mutations of hLADH. In the absence of high resolution mutant
structures these pieces of information are crucial for the mechanistic investigation of the molecular
pathogeneses of the hLADH protein. In the present work we analyzed by molecular dynamics simulation
the structural changes induced in the low-pH conformation of hLADH by five pathogenic mutations of
hLADH; the structures of these disease-causing mutants of hLADH have never been examined before.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Human dihydrolipoamide dehydrogenase (hLADH) is a flavoen-
zyme component (E3) of the human alpha-ketoglutarate dehydrogen-
ase complex (hα-KGDHc) and few other dehydrogenase complexes;
hLADH oxidizes the E2-bound dihydrolipoate while reducing NADþ to
NADH. In both the forward and reverse reaction, in the latter hα-
KGDHc and isolated E3 consume NADH, the enzyme generates
superoxide and hydrogen peroxide (ROS; reactive oxygen species)
[1–4]. Excess superoxide and H2O2 generation inmitochondria induces
oxidative stress [5,6]. ROS generation by hα-KGDHc and isolated E3
becomes dominant under pathological conditions at elevated NADH/
NADþ ratios and/or decreased pH (in acidosis) [1,2]. ROS generation
by hα-KGDHc was suggested to be the major source of oxidative stress
in senescence/aging, ischemia-reperfusion and neurodegenerative
diseases [7–11].
Pathogenic hLADH mutations result in E3-deficiency in humans
[12]. The mutations primarily affect tissues that have high O2 demand,
thus E3-deficiency often presents with severe cardiological or neuro-
logical symptoms. Clinical complications, which ultimately may lead
to premature death, are usually observed already in the neonatal age
[12] and are generally accompanied by lactic acidosis. hLADH presents
a distinct conformation under acidosis (pH 5.5–6.8) with lower
physiological activity; ROS generation activity of hLADH is also
accredited to this conformation. Our laboratory recently reported that
disease-causing mutations, besides their basal effect of lowering the
physiological activity of hLADH, also modulate the ROS-generating
capacity of hLADH; four mutations significantly stimulated while few
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others significantly lowered the rate of ROS generation by hLADH [13].
While elevated ROS generation by a specific mutation is implicated in
pathogenesis [14] and could be a target in the treatment [15],
elucidation of the mechanism by which other mutations attenuate
ROS production by hLADH is potentially also important to reveal the
nature of molecular interactions in the hLADH active center crucial for
the development of this potentially beneficial effect [16]. Although
multiple crystal structures for hLADH have been published, the only
report on the low-pH (ROS-generating) conformation of hLADH is a
molecular dynamics (MD) study from our own laboratory. In that
work the effects of eight disease-causing mutations on the low-pH
conformation of hLADH were also analyzed by MD simulations [17].
In the present contribution we analyzed by molecular
dynamics simulation the structural changes induced in the low-
pH conformation of hLADH by five pathogenic mutations of
hLADH; the structures of these disease-causing mutants of hLADH
have never been examined before (R447G [18], G101del [19],
I445M [20], I12T [12], and I318T [21]). The structural information
revealed here are to be used in the mechanistic evaluation of the
molecular pathogeneses of these disease-causing hLADH mutants.
2. Methods
The applied methodology was published before [17] and is
summarized below with the few modifications detailed.
Structure calculations and manipulations were carried out in
XPLOR-NIH [22] and VMD [23] under Linux on a calculation
architecture of a Hewlett-Packard supercomputer with a
CP4000BL blade technology and AMD Opteron 6174 Magny Cours
processors with 12 cores (the total number of cores was 2304);
parallelization was not applied. XPLOR-NIH was compiled in-
house due to specific adjustments made to the source code.
2.1. Mutant structure building and molecular dynamics simulations
From the eight monomers in the asymmetric unit (pdb code:
1zmc) the functional dimer of A and B was used. After performing
initial adjustments to coordinate files and introducing amino acid
changes at designated sites, structures for calculations simulating
low pH (o6.0) were created by protonating at both nitrogen atoms
all the 12 His side chains which are present in each monomer. For
simulations in H2O with physiological ionic strength the dimeric
holoenzyme was surrounded with a 12 Å water shell supplemented
by 150 mM KCl. After an initial stage of calculations comprising
conjugate gradient energy minimization steps, atoms were all
assigned to a uniform initial distribution of velocities. A heating
scheme of gradual steps was applied using an initial temperature of
100 K and a final temperature of 310 K (37 1C; with 10 K increase at
a time) permitting 10 ps simulation time at each temperature
(10,000 steps with 1 fs integration time). H2O molecules were
retained during simulation by the application of a deformable
stochastic boundary potential [24]. To secure adequate temperature
equilibration during temperature incrementation steps up to 37 1C,
a water shell with two layers and Langevin dynamics were applied
[25]. The coordinates of 37 1C underwent 2000 steps of energy
minimization followed by 2 ns of molecular dynamics simulation
with the temperature control switched to temperature coupling
[26] (to 310 K); initial velocities were reassigned by a Maxwellian
distribution. Molecular dynamics simulations were performed in
the Cartesian space applying the third-order finite difference
approximation [24]. In water, two parallel experiments were
performed and for the initial velocity assignments two different
random seeds were applied. As a reference, simulations were
repeated in vacuum with a single seed and identical settings except
for the final simulation time which was set to 10 ns.
2.2. Analysis of structures
As a first step of analysis, RMS difference curves, relative to the
initial structures, as a function of simulation time were generated
from the trajectories. RMSD curves were created also for the domain
and the 10 amino acid stretch bore the mutation. 10 ps long samples
(20 coordinate sets with 1 fs integration time and every 500th step
recorded) were collected from the stable parts of the trajectories and
averaged. Averaged structures were carried over in case 10% of the
protein chain or less was found beyond the solvation sphere after
simulation. Structures were energy minimized in two subsequent
stages of 2000 steps each, first with planarity restraints and then
with constraints imposed on the isoalloxazine ring of FAD. Final
structures were validated inside XPLOR-NIH and on the MOLPROB-
ITY server (molprobity.biochem.duke.edu). Mutants were fitted to the
wild-type structure through Cα atoms of the dimer and the
respective overall RMSD values were calculated. Residue displace-
ment plots were generated after calculating backbone RMSDs on a
per residue basis relative to the reference structure. Deviations of
greater than 10 Å (in water) or 7 Å (in vacuum) were filtered. Eighty
four inter-atomic distances crucial in the hLADH structure were
identified (VMD) and measured (XPLOR-NIH) in the FAD/NADþ/
NADH or the lipoate binding sites or on the dimerization surface;
respective distances in mutants and wt-LADH were compared.
All settings and procedures not detailed here were identical to
the settings and procedures applied before in [17].
3. Results
3.1. Analysis of trajectory information
During building mutant structures chirality of the new amino
acid was always verified. H2O molecules have not escaped across
the boundary wall when simulations were carried out in water.
Temperature was found to be very stable during all simulation
experiments. At least one or two of the three RMSD curves (full
protein, domain, peptide stretch) calculated from trajectories
recorded in a vacuum became practically stabilized on or before
2 ns for each mutant (representative data are shown in Fig. 1);
flexible loops and/or terminal stretches are the structural elements
that may result in drifting RMSD curves. This justified the applied
length of the very calculation demanding simulations in water
(2 ns). Difference from the regular order of the magnitudes of the
three RMSD curves (full protein4domainZpeptide stretch),
where the peptide stretch deviated the most as a function of time,
was seen only in case of G101del in water (data not shown). A
conclusion was drawn that G101del leads to a robust but rather
local effect while the other four mutations altered the structure on
a more extended scale. All averaged structures calculated from the
stable parts of the trajectories showed less than 10% peripheral
amino acids outlying beyond the water shell. No energy-
minimized protein structures showed any deviation in bond
lengths or angles. Only those structures were analyzed further
though that possessed at least one FAD with reasonably planar
isoalloxazine ring structure. Ramachandran outliers that were not
in or entirely borderline to the allowed regions were always r1%
(Fig. S1).
3.2. Analysis of the mutant structures
Mutant structures (Fig. 2) were fitted to the wild-type structure
(Fig. S2A-B) in both simulation environments and respective full-
structure RMSDs were calculated (Table 1). The results show no
considerable inter-monomeric displacement for any of the
mutants, which is in accordance with our data on the other eight
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hLADH pathogenic mutants [13,17]. As calculated in [17], RMSDs
greater than 7.51 (in water) or 1.49 Å (in vacuum) provide
structures which are significantly different from WT-hLADH; all
mutants in Table 1 satisfy this requirement.
Amino acids that most significantly changed position upon
mutation were identified using residue displacement plots (resi-
due-level RMSDs; Fig. 3). Significant displacements were filtered
against functionally important residues in the active center, the
FAD and NADþ/NADH binding sites, the lipoic moiety binding site
and the homodimerization surface (Table 2); in Table 2 the
functional locations of the residues are also highlighted so that
the primarily affected regions could easily be identified. In Table 2
asterisks label residues that were identified multiple times from
the three parallel simulations; a residue marked with two aster-
isks is the most likely to be displaced in the mutant conformation
of the low-pH hLADH structure.
In the crystallographic study of WT-hLADH amino acids in
functional vicinity to NADþ(NADH)/FAD or on the homodimeriza-
tion surface or in the binding channel for lipoate were identified
[27]. It is also known which residues participate in the catalytic
action [28–31]. All of this information was used during the analysis
of residue displacement plots (see above), but also to map the
wild-type structure for functionally representative interatomic
distances; 84 such distances (Fig. S3) were selected after the
manual inspection of the WT-hLADH structure and screened for
in all recorded trajectories. As NADþ/NADH were not included in
simulation (as they are substrates), the NADþ/NADH binding site
was mapped via the most direct distances to FAD (Fig. S4); FAD
stacks close and well-defined to NADH during catalysis. To
quantify potential monomerization upon simulation, representa-
tive inter-monomeric distances were also specified and deter-
mined. Every designated distance was determined both in the
mutants and the respective wild-type structures (Fig. 4), and those
with significant deviation were listed also in Table 2 under
‘structure mapping’.
4. Discussion
The structural information revealed here is to be applied in
mechanistic studies addressing the elucidation of the molecular
pathogeneses of disease-causing mutant hLADH proteins.
We identified, with molecular dynamics simulation, the puta-
tive structural changes, including the most deviating amino acids
(from residue displacement plots) and interatomic distances (from
structure mapping) in functionally critical regions, in human LADH
bearing five different pathogenic (disease-causing) amino acid
substitutions relative to the wild-type structure. Amino acids
and interatomic distances identified with deviations under the
filter limits may also possess crucial structural information, never-
theless, our primary goal here was to identify amino acid residues
and interatomic distances of structural and functional significance,
upon the previously determined crystal structure of WT-hLADH
determined at physiological pH, which deviate the most relative to
the wild-type structure. These specific amino acid deviations
identified in functionally significant regions by molecular
dynamics simulations might contribute to the development and
dysfunction of low-pH pathogenic mutant hLADH structures and
thus their further individual analysis ought to be addressed in
future structural and mechanistic studies.
A pathogenic amino acid substitution can cause local and/or
distant effects in the structure of a protein. In either case,
functional units might be significantly displaced as a whole in
the mutant protein, but still kept relatively intact in the internal
structure. With residue displacement plots, overall distortions of
the structure were tracked (projected to the individual amino acid
level) while using structure mapping, all the relevant changes
inside the functionally important structural units could be deter-
mined. Significantly deviating residues or distances identified in a
pathogenic mutant multiple times in different simulation experi-
ments are of special interest. Amino acids affected by the muta-
tions in the low-pH conformation may also contribute to the
molecular dysfunction of the physiological hLADH conformation
(in terms of loss in physiological hLADH activity); nevertheless,
analysis of the low-pH conformation is more justified due to the
pathologically relevant usual condition for atypical E3-deficiency
(acidosis). Structural alterations induced by the mutations may
also result in changes in the ROS-generating behavior of the low-
pH conformation of hLADH; for these five pathogenic mutants of
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Fig. 1. Representative RMSD curves for the MD simulation trajectories of the I445M
mutant of the low-pH hLADH structure. RMSDs were calculated for Cαs from both
monomers relative to the initial structure in vacuum (A) or in water plus 150 mM
KCl (B) (I445M structure #1). The three curves with different colors represent (for A
and B) RMSDs calculated using the full structure (blue), the domain carrying the
actual mutation (red) or a 10 amino acid stretch that holds the mutation in the
middle (green). Arrows designate the points of sampling the trajectories. (For
interpretation of the references to color in this figure legend, the reader is referred
to the web version of this article.)
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Fig. 2. Structural models for wild-type (WT) hLADH and its five pathogenic mutants (structures #1) in their low-pH forms in water plus ions. Only monomer A is shownwith
different colors for domains: FAD-binding domain (1–149) – purple, NADþ/NADH-binding domain (150–282) – green, central domain (283–350) – orange, and interface
domain (351–474) – blue. Structures were created and rendered in Pymol. Representative fittings of I318T- or G101del-hLADH (low-pH) to WT-hLADH (low-pH) can be seen
in Fig. S2A,B. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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Table 1
Fitting simulated structures to reference structuresa.
Structure RMSD RMSD RMSD
(Å, protein) (Å, FAD-A) (Å, FAD-B)
R447G #1 11.65 4.88 3.74n
R447G #2 10.48 3.26 4.69n
G101del #1 9.38 4.14 3.62n
G101del #2 7.68 4.45 4.44
I445M #1 12.28 4.36 4.40
I445M #2 8.03 3.38 2.92n
I12T #1 8.99 4.42 4.20n
I12T #2 11.23 4.14 5.05n
I318T #1 8.90 3.81n 4.87
I318T #2 11.25 3.61 4.14
R447G 5.45 4.55n 4.19
G101del 6.14 2.66 3.37n
I445M 4.70 1.94 3.04
I12T 5.54 2.39 4.63
I318T 4.58 4.55n 3.86
a RMSDs were calculated for Cα atoms from both monomers. Data above the bold separation line are from simulations in water plus ions while under the line are from
simulations in vacuum. Asterisks label FADs that were not approved for planar isoalloxazine ring.
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Fig. 3. Representative residue displacement plot for the simulated R447G mutant structure (#2) in water plus ions relative to the respective low-pH WT-hLADH structure.
The plot represents RMS differences as a function of residue number after fitting the respective E3-A monomers. RMSDs are rms-averaged over the backbone atoms of each
residue. RMSDs greater than 10 Å (in water plus ions) or 7 Å (in vacuum) are filtered out from plots and collected in Table 2 under the “residue displacement” columns.
Table 2
Significant amino acid deviations in the low-pH hLADH structure induced by pathogenic mutations identified from residue displacement plots and structure mappinga
Protein Residue displacement
(water plus ions)
Residue displacement (vacuum) Structure mapping (water plus ions) Structure mapping
(vacuum)
G101del 209n, 155n 16f, 17f, 43f, 44f, 48f, 49f, 117f, 118f, 150f,
168f, 280f, 45a, 279n, 357n, 42l, 46l, 99l
36f, 119f, 280f, 340d–4470d, 444d–4380dn, 277n, 51l–4520 l 45a–4520a, 12f, 35f,
99l–3920 l
I12T 280fn, 155nn, 209n, 278n,
279nn, 438d, 444d, 447d,
460d
43f, 44f, 49f, 117f, 150f, 280fn, 279nn, 42l,
99l, 103l
36fnn, 37fn, 43f, 118f, 189f, 280f, 283f, 444d–4380dn, 460d–3330d,
277nn, 51l–4530 l
12f, 36fnn, 37fn,
99l–3920 l
I318T 280f, 155nn, 279n, 46l, 99l,
103l
185n, 340d 13f, 16f–45f, 36fn, 37fn, 43fn, 118f, 119fnn, 148f, 280f, 359fn, 444d–
4380dn, 460d–3330d, 188n, 277nn, 99l–332l, 51l–4530 l, 3920 l–4530 l
12f, 37fn, 117f,
119fnn, 45l–328l,
99l–3920 l
I445M 16fl, 209n, 19l, 46l, 340d 43f, 150f, 42l, 438d 16f–45f, 119fn, 444d–4380d, 277nn, 99l–332l, 51l–4530 l 119fn, 45l–328l,
99l–3920 l
R447G 48f, 49fn, 168fn, 280f, 45a,
209n, 210n, 19l, 46ln
49fn, 117f, 149f, 150f, 168fn, 326f, 327f,
50a, 279n, 51l
36f, 37fn, 43f, 117f, 118f, 119fn, 168f, 280f, 340d–4470dn, 277nn, 51l–
4520 l, 51l–4530 l, 103l–4520 l
12f, 35f, 37fn, 119fn,
460d–3330d
a Greater deviations of N- and C-terminal stretches in residue displacement plots were neglected in this table. Residue numbers are based on 474 amino acids (mature
protein); in case of G101del, a pseudo residue was included at position 101 during analysis to keep the original numbering scheme for clear comparison of affected amino
acids. Residues filtered from displacement plots showed higher than 7 (vacuum) or 10 Å (water plus ions) displacements relative to the respective reference structures and
were also previously identified as participants of crucial interactions in the original 1zmc structure (see below). Residues filtered from structure mapping presented with a
multiplication factor of higher than 2 for designated atom distances relative to the reference structures. Asterisks label residues positively filtered frommultiple analyses (e.g.
in vacuum and in water or in both structures in water); the number of asterisks indicates the number of cases a residue was positively filtered (double asterisks equals to
three positives). All structures were plotted and residues are presented even when filtered from one analysis (but fulfilled the requirements of the above filters). Subscripts
label locations of residues: active center – a, FAD binding site – f, NADþ/NADH binding site – n, lipoic moiety binding site – l, dimer interface – d. Some residues belong to
multiple categories. 0 labels the other monomer. For structure mapping FAD atoms are not included in this table, for those see Figs. S3 and S4.
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hLADH investigated here, there is no data regarding their ROS
generation capacities reported.
For evaluation of the structural changes, simulation results
obtained in water plus ions ought to be primarily considered. As
seen in Table 2 (and from the trajectory deviation curves as well)
G101del induced a rather local change (few significant changes in
the residue displacement plot and an intensive deviation of the
peptide stretch in the trajectory in water plus ions, see Section 3).
For the other four mutations, more considerable sets of residues
and functional distances were found to be significantly affected,
virtually in all regions important for hLADH function (Table 2). As
seen in Fig. 2, the overall structure of the FAD prosthetic group was
also generally affected by the mutations which might also poten-
tially contribute to dysfunction; the greatest change was detected
in R447G-hLADH where the overall shape of FAD was converted to
a rather rare U-shaped FAD structure, similar to what was found in
DNA-photolyase [32].
Mechanistic validation of the structural information reported
here ought to result in new structural restraints and constraints
which can then be applied to further refine the simulated
structures until relevantly high resolution (NMR, X-ray) structures
are determined. NMR failed us to provide adequate signal disper-
sion due to the size of hLADH proteins (100 kDa) even at
900 MHz of proton while quality mutant crystals could neither
be grown hitherto from any of the pathogenic mutants of hLADH;
this is why MD simulation became the method of choice for the
structure analysis of these pathogenic forms of hLADH and there is
no straightforward technique hence to experimentally validate
these simulated structures, yet. The structural data provided by
these MD simulation experiments are of low resolution, hence an
atomic level evaluation of the structures ought not to be per-
formed at this stage of analysis. These simulated structures will be
refined later upon an extensive mechanistic evaluation and hence
are only adequate at this stage to serve as preliminary structural
information for the informed selection of amino acids in a
mechanistic evaluation study. In a mechanistic study, typically
implicated amino acids are labeled, modified or substituted and
changes in biophysical/biochemical parameters including spectro-
scopic (e.g. NMR, CD, UV, IR, ESR) and kinetic (like specific activity,
Vmax, KM, kcat/KM) information are recorded and evaluated for the
elucidation of the structure-based molecular mechanism [1,13,33–
35]. With both functional and (refined) structural information in
hand for all the 13 known pathogenic mutants of hLADH a
plausible attempt can then be made to assess the putative basis
of the atomic level relationship between phenotypic properties at
the molecular level, like loss of physiological activity and modula-
tion of ROS generation, and these (or all) simulated hLADH
structures.
Selective, rationally designed inhibitors against human hLADH
mutants presenting with high ROS generation are the future
alternatives of the non-selective antioxidant therapy. For this
purpose, deep insight into the disease-causing mutant structures
in a broader pH range and the relevant molecular mechanisms on
the atomic level is inevitable. The present work together with our
previous study [17] completes a preliminary structural investiga-
tion for all the disease-causing mutants of human LADH reported
in the clinical literature until today.
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